Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Obstructive sleep apnea (OSA) is a highly prevalent condition with few therapeutic options. To date there is no approved pharmacotherapy for this disorder, but several attempts have been made in the past and are currently ongoing to find one. The recent identification of multiple endotypes underlying this disorder has oriented the pharmacological research towards tailored therapies targeting specific pathophysiological traits that contribute differently to cause OSA in each patient. In this review we retrospectively analyze the literature on OSA pharmacotherapy dividing the medications tested on the basis of the four main endotypes: anatomy, upper airway muscle activity, arousal threshold and ventilatory instability (loop gain). We show how recently introduced drugs for weight loss that modify upper airway anatomy may play an important role in the management of OSA in the near future, and promising results have been obtained with drugs that increase upper airway muscle activity during sleep and reduce loop gain. The lack of a medication that can effectively increase the arousal threshold makes this strategy less encouraging, although recent studies have shown that the use of certain sedatives do not worsen OSA severity and could actually improve patients’ sleep quality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Prevalence of Sleep-Disordered Breathing in Adults
Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., & Hla, K. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws342 · Cited by 4,618
Benjafield, A. V., Ayas, N. T., Eastwood, P. R., Heinzer, R., Ip, M. S. M., Morrell, M. J., Nunez, C. M., Patel, S. R., Penzel, T., Pépin, J.-L., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30198-5 · Cited by 4,326 · cited 1×
“It is estimated that approximately 15% of males and 5% of women in North America are affected by this disorder [3], and recently, a global estimate suggested that more than 930 million people suffer from at least mild OSA [4].”
BackgroundEpidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109080 · Cited by 4,244
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943 · cited 1×
“It was tested in several trials on OSA patients as a potential non-myorelaxant hypnotic, and it is currently prescribed as a third-line pharmacologic treatment for chronic insomnia in adults [131].”
BackgroundAdherence to Continuous Positive Airway Pressure Therapy: The Challenge to Effective Treatment
Weaver, T. E., & Grunstein, R. R. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-119mg · Cited by 1,680 · cited 11×
“Multiple randomized trials comparing the effect of oxygen to CPAP and sham air for variable duration (2 weeks to 3 months) were performed [145–149].”
BackgroundInfluentialSawyer, A. M., Gooneratne, N. S., Marcus, C. L., Ofer, D., Richards, K. C., & Weaver, T. E. (2011) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.01.003 · Cited by 900
Azarbarzin, A., Sands, S. A., Stone, K. L., Taranto-Montemurro, L., Messineo, L., Terrill, P. I., Ancoli-Israel, S., Ensrud, K., Purcell, S., White, D. P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy624 · Cited by 893 · cited 3×
“In the near future, thanks to developing technologies, we also hope that the efficacy of new pharmacotherapies and alternative treatments will be tested on other metrics, such as the hypoxic burden that better characterizes the ventilatory burden of sleep apnea [17] and its consequences.”
BackgroundSelf-citationPedrosa, R. P., Drager, L. F., Gonzaga, C. C., Sousa, M. G., de Paula, L. K. G., Amaro, A. C. S., Amodeo, C., Bortolotto, L. A., Krieger, E. M., Bradley, T. D., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.179788 · Cited by 668
on behalf of the SCALE study group, Blackman, A., Foster, G. D., Zammit, G., Rosenberg, R., Aronne, L., Wadden, T., Claudius, B., Jensen, C. B., & Mignot, E. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.52 · Cited by 583
Role of Arousals in the Pathogenesis of Obstructive Sleep Apnea
Younes, M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-1023oc · Cited by 456 · cited 1×
“Indeed, some studies suggest that airway patency may be restored prior to, or in the absence of, cortical arousal [8,106].”
BackgroundEckert, D. J., Owens, R. L., Kehlmann, G. B., Wellman, A., Rahangdale, S., Yim-Yeh, S., White, D. P., & Malhotra, A. (2011) · Clinical Science · doi:10.1042/cs20100588 · Cited by 367
Self-citationSleepiness in patients with moderate to severe sleep-disordered breathing
Kapur, V. K., Baldwin, C. M., Resnick, H. E., Gottlieb, D. J., & Nieto, F. J. (2005) · SLEEP · doi:10.1093/sleep/28.4.472 · Cited by 338
Clinical Predictors of the Respiratory Arousal Threshold in Patients with Obstructive Sleep Apnea
Edwards, B. A., Eckert, D. J., McSharry, D. G., Sands, S. A., Desai, A., Kehlmann, G., Bakker, J. P., Genta, P. R., Owens, R. L., White, D. P., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0718oc · Cited by 312 · cited 1×
“A low arousal threshold was found in 88%, 73% and 23% of patients with mild, moderate and severe OSA, respectively, suggesting that this endotype is more important in patients with a mild rather than a severe disorder [12].”
BackgroundSelf-citationEdwards, B. A., Sands, S. A., Eckert, D. J., White, D. P., Butler, J. P., Owens, R. L., Malhotra, A., & Wellman, A. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.223925 · Cited by 298 · cited 3×
“tested the effect of acetazolamide 500 mg twice daily on the OSA phenotypic traits and OSA severity [137].”
BackgroundInfluentialSelf-citationTaranto-Montemurro, L., Messineo, L., Sands, S. A., Azarbarzin, A., Marques, M., Edwards, B. A., Eckert, D. J., White, D. P., & Wellman, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201808-1493oc · Cited by 297 · cited 2×
“A second trial performed by our group confirmed that atomoxetine administered alone did not improve OSA severity in a sample of nine moderate-to-severe OSA patients [82].”
BackgroundSelf-citationSands, S. A., Edwards, B. A., Terrill, P. I., Taranto-Montemurro, L., Azarbarzin, A., Marques, M., Hess, L. B., White, D. P., & Wellman, A. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1435oc · Cited by 291
Self-citationQuantifying the ventilatory control contribution to sleep apnoea using polysomnography
Terrill, P. I., Edwards, B. A., Nemati, S., Butler, J. P., Owens, R. L., Eckert, D. J., White, D. P., Malhotra, A., Wellman, A., & Sands, S. A. (2015) · European Respiratory Journal · doi:10.1183/09031936.00062914 · Cited by 289
Self-citationGaddam, K., Pimenta, E., Thomas, S. J., Cofield, S. S., Oparil, S., Harding, S. M., & Calhoun, D. A. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2009.96 · Cited by 289 · cited 1×
“[39] added spironolactone and measured the effect on AHI after eight weeks of treatment.”
BackgroundA method for measuring and modeling the physiological traits causing obstructive sleep apnea
Wellman, A., Eckert, D. J., Jordan, A. S., Edwards, B. A., Passaglia, C. L., Jackson, A. C., Gautam, S., Owens, R. L., Malhotra, A., & White, D. P. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00972.2010 · Cited by 283
Self-citationEffects of Mouth Opening on Upper Airway Collapsibility in Normal Sleeping Subjects
Meurice, J. C., Marc, I., Carrier, G., & Sériès, F. (1996) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.153.1.8542125 · Cited by 276 · cited 1×
“This is consistent with previous findings suggesting that mouth opening (and consequently mouth breathing) is associated with increased upper airway collapsibility and total respiratory resistance [46].”
ResultHudgel, D. W., Patel, S. R., Ahasic, A. M., Bartlett, S. J., Bessesen, D. H., Coaker, M. A., Fiander, P. M., Grunstein, R. R., Gurubhagavatula, I., Kapur, V. K., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1326st · Cited by 266
Protriptyline in Obstructive Sleep Apnea: A Double-Blind Trial
Brownell, L. G., West, P., Sweatman, P., Acres, J. C., & Kryger, M. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210213071701 · Cited by 233 · cited 3×
“Three randomized controlled trials [65,76,79] and several observational studies [77,80,81] assessed the effects of protriptyline on OSA severity.”
BackgroundMarshall, N. S., Yee, B. J., Desai, A. V., Buchanan, P. R., Wong, K. K., Crompton, R., Melehan, K. L., Zack, N., Rao, S. G., Gendreau, R. M., et al. (2008) · Sleep · doi:10.1093/sleep/31.6.824 · Cited by 224
A simplified method for determining phenotypic traits in patients with obstructive sleep apnea
Wellman, A., Edwards, B. A., Sands, S. A., Owens, R. L., Nemati, S., Butler, J., Passaglia, C. L., Jackson, A. C., Malhotra, A., & White, D. P. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00747.2012 · Cited by 222
Self-citationMarked reduction in obstructive sleep apnea severity in slow wave sleep
Ratnavadivel, R., Chau, N., Stadler, D., Yeo, A., McEvoy, R. D., & Catcheside, P. G. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27651 · Cited by 207
Guo, J., & Ikeda, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.665 · Cited by 190
Winslow, D. H., Bowden, C. H., DiDonato, K. P., & McCullough, P. A. (2012) · Sleep · doi:10.5665/sleep.2204 · Cited by 163
Sands, S. A., Eckert, D. J., Jordan, A. S., Edwards, B. A., Owens, R. L., Butler, J. P., Schwab, R. J., Loring, S. H., Malhotra, A., White, D. P., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0783oc · Cited by 150
Self-citationSerotonin Agonists and Antagonists in Obstructive Sleep Apnea: Therapeutic Potential
Veasey, S. C. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256636 · Cited by 129 · cited 5×
“The complexity of the serotonergic system is represented by the presen e of seven different receptor families that are distributed in both the per pheral a d cen ral n rvous systems and can be either exci atory or inhibi ory [56].”
BackgroundInfluentialRole of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome
Whyte, K. F., Gould, G. A., Airlie, G. A., Shapiro, C. M., & Douglas, N. J. (1988) · Sleep · doi:10.1093/sleep/11.5.463 · Cited by 128 · cited 3×
“Three randomized controlled trials [65,76,79] and several observational studies [77,80,81] assessed the effects of protriptyline on OSA severity.”
BackgroundKasai, T., Bradley, T. D., Friedman, O., & Logan, A. G. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000047 · Cited by 127 · cited 1×
“[40] tested the effect of spironolactone with”
Treatment of Obstructive Sleep Apnea
Phillips, B. A., Schmitt, F. A., Berry, D. T. R., Lamb, D. G., Amin, M., & Cook, Y. R. (1990) · Chest · doi:10.1378/chest.98.2.325 · Cited by 127
Trazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold
Smales, E. T., Edwards, B. A., Deyoung, P. N., McSharry, D. G., Wellman, A., Velasquez, A., Owens, R., Orr, J. E., & Malhotra, A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201408-399oc · Cited by 127 · cited 1×
“[134] showed that trazodone 100 mg reduced the AHI by 26% in 15 unselected patients with an AHI ≥10 events/h, although the arousal threshold was unchanged between nights.”
BackgroundSelf-citationEdwards, B. A., Sands, S. A., Owens, R. L., Eckert, D. J., Landry, S., White, D. P., Malhotra, A., & Wellman, A. (2016) · Sleep · doi:10.5665/sleep.6226 · Cited by 125
Self-citationAcute effects of paroxetine on genioglossus activity in obstructive sleep apnea
Berry, R. B., Yamaura, E. M., Gill, K., & Reist, C. (1999) · Sleep · doi:10.1093/sleep/22.8.1087 · Cited by 111
Trazodone increases arousal threshold in obstructive sleep apnoea
Heinzer, R. C., White, D. P., Jordan, A. S., Lo, Y. L., Dover, L., Stevenson, K., & Malhotra, A. (2008) · European Respiratory Journal · doi:10.1183/09031936.00067607 · Cited by 110
State-dependent and reflex drives to the upper airway: basic physiology with clinical implications
Horner, R. L., Hughes, S. W., & Malhotra, A. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00531.2013 · Cited by 104
The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea
Yee, B. J., Phillips, C. L., Banerjee, D., Caterson, I., Hedner, J. A., & Grunstein, R. R. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803363 · Cited by 87 · cited 1×
“[31] tested the effect of sibutramine, a serotonin and norepinephrine reuptake inhibitor, in combination with a weight loss program, in 87 middle-aged obese patients with OSA.”
BackgroundReduction of Sleep-disordered Breathing after Physostigmine
Hedner, J., Kraiczi, H., Peker, Y., & Murphy, P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200211-1344oc · Cited by 81 · cited 1×
“[174] tested a continuous infusion of physostigmine, another acetylcholinesterase inhibitor, vs.”
BackgroundEspinoza, H., Antic, R., Thornton, A. T., & McEvoy, R. D. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.1.80 · Cited by 73 · cited 1×
“[165] showed no effect of aminophylline infusions (versus saline) on OSA severity in a group of 10 patients in a one-night crossover trial.”
BackgroundBreath‐holding as a means to estimate the loop gain contribution to obstructive sleep apnoea
Messineo, L., Taranto‐Montemurro, L., Azarbarzin, A., Oliveira Marques, M. D., Calianese, N., White, D. P., Wellman, A., & Sands, S. A. (2018) · The Journal of Physiology · doi:10.1113/jp276206 · Cited by 72
Self-citationSibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Ferland, A., Poirier, P., & Sériès, F. (2009) · European Respiratory Journal · doi:10.1183/09031936.00167308 · Cited by 43 · cited 1×
“[32] compared treatment with sibutramine and dietary restriction in 22 OSA patients vs CPAP in 18 patients for one year.”
MethodAcar, M., Cingi, C., Sakallioglu, O., San, T., Yimenicioglu, M. F., & Bal, C. (2013) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2013.27.3921 · Cited by 38
Li, Y., Owens, R. L., Sands, S., Orr, J., Moraes, W., DeYoung, P., Smales, E., Jen, R., & Malhotra, A. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-384oc · Cited by 29 · cited 1×
“[173] tested the effect of donepezil on OSA severity, arousal threshold and loop gain.”
Background
Cited by
Global burden of sleep‐disordered breathing and its implications
Lyons, M. M., Bhatt, N. Y., Pack, A. I., & Magalang, U. J. (2020) · Respirology · doi:10.1111/resp.13838 · Cited by 422
Documento internacional de consenso sobre apnea obstructiva del sueño
Mediano, O., González Mangado, N., Montserrat, J. M., Alonso-Álvarez, M. L., Almendros, I., Alonso-Fernández, A., Barbé, F., Borsini, E., Caballero-Eraso, C., Cano-Pumarega, I., et al. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2021.03.017 · Cited by 250
Messineo, L., Eckert, D. J., Lim, R., Chiang, A., Azarbarzin, A., Carter, S. G., & Carberry, J. C. (2020) · The Journal of Physiology · doi:10.1113/jp280173 · Cited by 71
“…Teflon-coated intramuscular fine-wire electrodes (no. 791500; A-M Systems Inc., Sequim, WA, USA) were inserted sublingually ( 3–4 cm either side of the frenulum) using a 25-gauge needle, following surface anaesthesia (1% lignocaine), as described previously (Taranto-Montemurro et al. 2019a).”
BackgroundMethodSelf-citationStandardized framework to report on the role of sleeping position in sleep apnea patients
Ravesloot, M. J. L., Vonk, P. E., Maurer, J. T., Oksenberg, A., & de Vries, N. (2021) · Sleep and Breathing · doi:10.1007/s11325-020-02255-2 · Cited by 22
Metadata
- Authors
- Taranto-Montemurro, L., Messineo, L., & Wellman, A.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-11-02
- Volume
- 8
- Issue
- 11
- Pages
- 1846
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2988012158
- Cited by
- 110
- References
- 45
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.